2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theAnkylosing Spondylitis Market?

The surge in the elderly population is predicted to fuel the expansion of the ankylosing spondylitis market. The term geriatric population pertains to a rise in the number of older people resulting from changes in a population’s age structure. This demographic transition has led to an increase in the number and percentage of people aged 60 and above. Treatments and medications for ankylosing spondylitis assist in enhancing mobility and managing pain among seniors suffering from this condition. For example, data from the United Nations Department of Economic and Social Affairs (UN DESA), a department of the UN Secretariat based in the US, predicts a significant increase in the global population of individuals aged 65 and above. The number is expected to more than double, rising from 761 million in 2021 to 1.6 billion by 2050. Therefore, the growth in the elderly population is facilitating the expansion of the ankylosing spondylitis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

#What Long-Term Growth Rate is Expected for theAnkylosing Spondylitis Market Between 2025 and 2034?

There has been substantial growth in the ankylosing spondylitis market in the past few years. The market, which is poised to surge from $5.9 billion in 2024 to $6.36 billion in 2025, will experience a compound annual growth rate (CAGR) of 7.8%. This notable growth in the historic period can be credited to factors such as the discovery of hla-b27, the development of biologic treatments, methods for pain management, patient advocacy and awareness initiatives, NSAIDS, and disease-modifying drugs.

The market for ankylosing spondylitis is projected to witness robust growth in the coming years, with an estimated valuation of $8.71 billion by 2029. This signifies a compound annual growth rate (CAGR) of 8.2%. The projected growth during this period can be related to factors such as the individualized medicine approach, the creation of novel biologics, early screening and intervention, management of lifestyle and diet, and innovations in telemedicine and remote monitoring. Other significant trends for the forecast period encompass the availability of biosimilics, targeted pain treatments, a focus on patient-reported outcomes (pros), community support initiatives, and exploration of regenerative medicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11962

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theAnkylosing Spondylitis Market?

Emerging therapeutic solutions are increasingly becoming a dominant trend in the ankylosing spondylitis market. Firms involved in the sector are progressing new treatments to maintain their market status. For example, in April 2022, leading American biopharma company AbbVie Inc. reported the endorsement of RINVOQ by the U.S. Food and Drug Administration (FDA) for the treatment of adults dealing with active ankylosing spondylitis (AS). This offers a novel oral solution for patients who have shown no response to TNF blockers, exhibiting remarkable enhancement in disease symptoms such as back pain and physical function. The swift efficiency and safety demonstrated in clinical trials position it as a significant breakthrough in managing this persistent inflammatory disease, extending the range of treatment options for patients.

Who Are the Key Market Players Influencing the Growth of the Corn and Ankylosing Spondylitis Industry?

Major companies operating in the ankylosing spondylitis market include Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

Which Key Market Segments Comprise the Ankylosing Spondylitis Market and Drive Its Revenue Growth?

The ankylosing spondylitis market covered in this report is segmented –

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery

2) By Molecule: Biologics, Biosimilar, Small Molecules

3) By Route Of Administration: Parenteral, Oral, Other Routes

4) By Application: Juveniles, Adults

5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users

Subsegments:

1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs, Prescription NSAIDs

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted DMARDs

3) By Biological Therapies: TNF Inhibitors, IL-17 Inhibitors

4) By Steroids: Oral Steroids, Injectable Steroids

5) By Physical Therapies: Physiotherapy, Exercise Programs

6) By Surgery: Joint Replacement Surgery, Spinal Surgery

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11962&type=smp

Which Regions Are Emerging as Leaders in the Ankylosing Spondylitis Market?

North America was the largest region in the ankylosing spondylitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Ankylosing Spondylitis Maret 2025, By The Business Research Company:

Luxury Hair Care Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/luxury-hair-care-products-global-market-report

Retail And Wholesale Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/retail-and-wholesale-global-market-report

Personal Care Ingredients Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/personal-care-ingredients-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: